Waldenstrom macroglobulinemia
Showing 26 - 50 of 503
Waldenstrom Macroglobulinemia Trial in Boston (Loncastuximab Tesirine, Dexamethasone)
Recruiting
- Waldenstrom Macroglobulinemia
- Loncastuximab Tesirine
- Dexamethasone
-
Boston, MassachusettsDana Farber Cancer Institute
Mar 1, 2022
Waldenstrom Macroglobulinemia, Waldenstrom's Disease, Waldenström; Hypergammaglobulinemia Trial in New York (Ibrutinib,
Recruiting
- Waldenstrom Macroglobulinemia
- +6 more
-
New York, New YorkWeill Cornell Medicine
Dec 21, 2021
Waldenstrom Macroglobulinemia, MYD88 Gene Mutation Trial in Boston (IBRUTINIB, Venetoclax)
Active, not recruiting
- Waldenstrom Macroglobulinemia
- MYD88 Gene Mutation
-
Boston, Massachusetts
- +1 more
Apr 1, 2022
MRD and Clonal Evolution in Waldenström's Macroglobulinemia and
Active, not recruiting
- Waldenstrom Macroglobulinemia
- MRD and clonal evolution
-
Milano, MI, Italy
- +13 more
Nov 2, 2022
Clinical, Laboratory and Epidemiologic Characterization of
Recruiting
- Waldenstrom Macroglobulinemia
- +4 more
-
Bethesda, Maryland
- +1 more
Jan 25, 2023
Waldenstrom Macroglobulinemia Trial in United States (Umbralisib)
Completed
- Waldenstrom Macroglobulinemia
-
Washington, District of Columbia
- +3 more
Oct 19, 2022
Follicular B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Recurrent, Mantle Cell Lymphoma Refractory Trial in Orange,
Recruiting
- Follicular B-cell Non-Hodgkin's Lymphoma
- +7 more
- MB-106
-
Orange, California
- +3 more
Nov 1, 2022
Patients Previously Treated WithMustang Bio CAR-T Cell
Enrolling by invitation
- Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- +10 more
- Prior MB-102 CAR-T cell investigational product.
- Prior MB-106 CAR-T cell investigational product.
-
Duarte, California
- +4 more
Dec 8, 2022
Waldenström's Macroglobulinemia (WM) Trial in China (Zanubrutinib)
Completed
- Waldenström's Macroglobulinemia (WM)
-
Beijing, Beijing, China
- +10 more
Mar 7, 2022
Waldenstrom Macroglobulinemia Trial in Austria, Germany, Greece (Carfilzomib + Ibrutinib, Ibrutinib)
Recruiting
- Waldenstrom Macroglobulinemia
- Carfilzomib + Ibrutinib
- Ibrutinib
-
Salzburg, Austria
- +16 more
Mar 11, 2022
Waldenström Macroglobulinemia Trial in Vandoeuvre les Nancy (Blood or bone marrow samples)
Completed
- Waldenström Macroglobulinemia
- Blood or bone marrow samples
-
Vandoeuvre les Nancy, FranceCHRU Nancy
Aug 1, 2021
Mantle Cell Lymphoma, Peripheral T-cell Lymphoma (PTCL), Cutaneous T-cell Lymphoma (CTCL) Trial in Augusta, Nashville, Houston
Recruiting
- Mantle Cell Lymphoma
- +9 more
- L-Bcl-2 antisense oligonucleotide
-
Augusta, Georgia
- +2 more
Nov 18, 2022
Waldenstrom Macroglobulinemia Trial in New York (Epratuzumab (hLL2- anti-CD22 humanized antibody))
Terminated
- Waldenstrom Macroglobulinemia
- Epratuzumab (hLL2- anti-CD22 humanized antibody)
-
New York, New York
- +1 more
Aug 12, 2021
Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,
Recruiting
- Waldenstrom Macroglobulinemia
- +8 more
- Iopofosine I 131 single dose
- +2 more
-
Redlands, California
- +42 more
Dec 30, 2022
Waldenstrom Macroglobulinemia Trial in Germany, Greece (Ibrutinib / Bortezomib / Rituximab)
Active, not recruiting
- Waldenstrom Macroglobulinemia
- Ibrutinib / Bortezomib / Rituximab
-
Berlin, Germany
- +14 more
Mar 7, 2022
Spanish Registry of Patients With IgM Monoclonal Gammopathies
Recruiting
- Waldenstrom Macroglobulinemia
-
Mieres, Asturias, Spain
- +24 more
Jul 5, 2022
IgA Monoclonal Gammopathy, IgG Monoclonal Gammopathy, IgM Monoclonal Gammopathy Trial in Atlanta (Rifaximin)
Recruiting
- IgA Monoclonal Gammopathy
- +8 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Oct 18, 2021
Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Huntsville, Bethesda (Ublituximab,
Terminated
- Non-Hodgkins Lymphoma
- +6 more
-
Huntsville, Alabama
- +1 more
May 5, 2022
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Diffuse Large B Cell Lymphoma (DLBCL) Trial in Manchester,
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
- +7 more
-
Manchester, United Kingdom
- +2 more
Aug 11, 2022
Asymptomatic COVID-19 Infection Laboratory-Confirmed, B-Cell Tumor, Chronic Lymphocytic Leukemia Trial in Rochester (Ibrutinib,
Withdrawn
- Asymptomatic COVID-19 Infection Laboratory-Confirmed
- +8 more
- Ibrutinib
- Quality-of-Life Assessment
-
Rochester, MinnesotaMayo Clinic in Rochester
Aug 2, 2022
Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-cell Marginal Zone, Lymphoma, Non-Hodgkin Trial in Worldwide (LOXO-338,
Active, not recruiting
- Leukemia, Lymphocytic, Chronic, B-Cell
- +6 more
-
Duarte, California
- +8 more
Jan 11, 2023
Hyperviscosity Syndrome, Waldenstrom Macroglobulinemia Trial in Amiens (other, biological, procedure)
Recruiting
- Hyperviscosity Syndrome
- Waldenstrom Macroglobulinemia
- fundoscopic picture
- +2 more
-
Amiens, FranceCHU Amiens
May 19, 2021